Paragon Private Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,311
| Closed | -$208K | – | 196 |
|
|
2024
Q4 | $208K | Sell |
2,311
-191
| -8% | -$17.2K | 0.1% | 163 |
|
|
2024
Q3 | $247K | Hold |
2,502
| – | – | 0.12% | 148 |
|
|
2024
Q2 | $232K | Sell |
2,502
-89
| -3% | -$8.25K | 0.13% | 142 |
|
|
2024
Q1 | $246K | Hold |
2,591
| – | – | 0.15% | 127 |
|
|
2023
Q4 | $231K | Sell |
2,591
-485
| -16% | -$43.3K | 0.16% | 124 |
|
|
2023
Q3 | $225K | Hold |
3,076
| – | – | 0.19% | 114 |
|
|
2023
Q2 | $256K | Hold |
3,076
| – | – | 0.2% | 109 |
|
|
2023
Q1 | $234K | Hold |
3,076
| – | – | 0.2% | 114 |
|
|
2022
Q4 | $255K | Hold |
3,076
| – | – | 0.23% | 111 |
|
|
2022
Q3 | $248K | Hold |
3,076
| – | – | 0.24% | 100 |
|
|
2022
Q2 | $228K | Hold |
3,076
| – | – | 0.24% | 94 |
|
|
2022
Q1 | $213K | Hold |
3,076
| – | – | 0.21% | 104 |
|
|
2021
Q4 | $344K | Buy |
+3,076
| New | +$344K | 0.31% | 81 |
|